Stedivaze News
Most Popular Stedivaze Story
Clinical Data inks $66M deal to acquire Adenosine
Clinical Data is buyout out the privately held Adenosine Therapeutics for $11 million, promissory notes totaling $25.2 million and up to $30 million in milestones. The acquisition of Adenosine... Read more...
Latest Headlines
- August 5, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
